Foresite Capital Management Ii, LLC Regenxbio Inc. Transaction History

Foresite Capital Management Ii, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 13, 2020	SELL	$27.75 - $43.44 $1.32 Million - $2.06 Million	-47,443 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$21.5 - $54.2 $1.02 Million - $2.57 Million	47,443 New	47,443 $1.54 Million

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Ii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Ii, LLC with notifications on news.